Fibrinolytic Treatment of Coronary Thrombosis

Fibrinolytic Therapy of Coronary Thrombosis.

Fibrinolytic treatment for recurrent left sided prosthetic valve thrombosis.

A bout 20–25% of patients develop recurrent thrombosis after successful thrombolysis for a first episode of prosthetic valve thrombosis (PVT). 2 Whereas fibrinolytic treatment (FT) is an acceptable modality of treatment for a first episode of PVT, there are few data on patients with recurrent PVT. We compared the outcome of FT in patients with recurrent PVT with those treated for a first episode.

Fibrinolytic therapy and deep venous thrombosis.

SIR,-Further to the interesting leading article "Nutrition and Sleep" (20 May, p. 418) one may ask whether sleep is not the "natural" state and wakefulness merely a res,pite for the satisfaction of instinctual (and socially inculcated) drives. The hibernating animal is unlikely to chance upon dangerous predators. On this model the satisfqction of drives would lead to sleep and their continued f...

Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment

A 26-year-old male admitted to the emergency department with a new-onset chest pain for two days. His physical examination was unremarkable. Electrocardiogram (ECG) showed biphasic T wave changes in leads V2-4 (Figure 1). The patient had a history of warfarin use for 6 months due to a deep vein thrombosis (DVT) suffered 2 years before. Bedside echocardiogram revealed slight hypokinesis of anter...

The modern treatment of coronary thrombosis with myocardial infarction.

C ORONARY thrombosis kills at least 200,000 people a year in the United States, and this figure will increase inexorably as the average age of our population continues to increase. It occurs in all ages but is predominantly encountered in persons over the age of 40. In general, it may be said that coronary thrombosis occurs at an average age which is approximately 6 years younger in men than in...